Oncology Institute Inc.

NASDAQ: TOI · Real-Time Price · USD
2.79
0.31 (12.50%)
At close: May 01, 2025, 3:59 PM
2.85
1.97%
After-hours: May 01, 2025, 07:38 PM EDT

Company Description

The Oncology Institute, Inc., an oncology company, provides medical oncology services in the United States.

Its services include physician services, in-house infusion and dispensary, clinical trial services, radiation, outpatient stem cell transplants and transfusions programs, and patient support.

The company also offers and manages clinical trial services, such as managing clinical trials, palliative care programs, and stem cell transplants services.

It serves adult and senior cancer patients.

The company operates 67 clinic locations.

The Oncology Institute, Inc. was founded in 2007 and is based in Cerritos, California.

Oncology Institute Inc.
Oncology Institute Inc. logo
Country United States
IPO Date Jun 4, 2020
Industry Medical - Care Facilities
Sector Healthcare
Employees 825
CEO Dr. Daniel Virnich FACHE, M.B.A., M.D.

Contact Details

Address:
18000 Studebaker Road
Cerritos, California
United States
Website https://theoncologyinstitute.com

Stock Details

Ticker Symbol TOI
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001799191
CUSIP Number 68236X100
ISIN Number US68236X1000
Employer ID 00-0000000
SIC Code 8011

Key Executives

Name Position
Dr. Daniel Virnich FACHE, M.B.A., M.D. Chief Executive Officer & Executive Director
Robert Carter Chief Financial Officer
Austin Lee Vice President of Accounting & Controller
Dr. Yale D. Podnos F.A.C.S., M.D., M.P.H. Chief Medical Officer
Jeremy N. Castle M.B.A. Chief Operations Officer
Jordan McInerney Chief Development Officer
Mark Hueppelsheuser Esq. General Counsel
Richard Alan Barasch Chairman of the Board
Stephen Cella Senior Vice President of Finance

Latest SEC Filings

Date Type Title
Apr 28, 2025 4/A [Amend] Filing
Apr 23, 2025 SCHEDULE 13D/A [Amend] Filing
Apr 08, 2025 D Filing
Apr 02, 2025 4 Filing
Apr 02, 2025 4 Filing
Apr 02, 2025 4 Filing
Apr 02, 2025 4 Filing
Mar 28, 2025 SCHEDULE 13D/A [Amend] Filing
Mar 28, 2025 4 Filing
Mar 28, 2025 4 Filing